CA1202581A
(en)
*
|
1980-03-27 |
1986-04-01 |
Saran A. Narang |
Adaptor molecules for dna and their application to synthesis of gene-derived products
|
ES8302096A1
(es)
|
1980-04-03 |
1982-12-16 |
Biogen Nv |
Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
|
US4874702A
(en)
*
|
1980-09-08 |
1989-10-17 |
Biogen, Inc. |
Vectors and methods for making such vectors and for expressive cloned genes
|
DK489481A
(da)
*
|
1980-11-10 |
1982-05-11 |
Searle & Co |
Plasmidvektor og frmgangsmaade til fremstilling deraf
|
US5525484A
(en)
*
|
1981-01-16 |
1996-06-11 |
Genome Therapeutics Corp. |
Recombinant DNA means and method for producing rennin, prorenin and pre-prorennin
|
BR8205954A
(pt)
*
|
1981-10-14 |
1983-09-13 |
Unilever Nv |
Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
|
JPS58110600A
(ja)
*
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
JPS58141796A
(ja)
*
|
1982-02-18 |
1983-08-23 |
Kyowa Hakko Kogyo Co Ltd |
ペプチドの製造法
|
EP0088994B1
(de)
*
|
1982-03-15 |
1991-06-19 |
Schering Corporation |
Hybride DNS, damit hergestellte Bindungszusammensetzung und Verfahren dafür
|
US4499188A
(en)
*
|
1982-05-05 |
1985-02-12 |
Cetus Corporation |
Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
|
US4863855A
(en)
*
|
1982-05-14 |
1989-09-05 |
The Research Foundation Of State University Of New York |
Novel cloning vehicles for polypeptide expression in microbial hosts
|
EP0108045B1
(de)
*
|
1982-10-25 |
1988-12-07 |
Monsanto Company |
RecA-Promotor abhängige Polypeptidherstellung
|
CA1252046A
(en)
*
|
1982-11-04 |
1989-04-04 |
Martin J. Cline |
Methods for oncogenic detection
|
DE3247922A1
(de)
*
|
1982-12-24 |
1984-06-28 |
Boehringer Ingelheim International GmbH, 6507 Ingelheim |
Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
|
US5169762A
(en)
*
|
1983-03-03 |
1992-12-08 |
Genentech, Inc. |
Human nerve growth factor by recombinant technology
|
DK161152C
(da)
|
1983-03-03 |
1991-11-11 |
Genentech Inc |
Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
|
US4701416A
(en)
*
|
1983-12-09 |
1987-10-20 |
Cetus Corporation |
Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
|
US4935370A
(en)
*
|
1983-12-23 |
1990-06-19 |
Pfizer Inc. |
Expression plasmids for improved production of heterologous protein in bacteria
|
JP2595205B2
(ja)
*
|
1984-02-08 |
1997-04-02 |
カロイン コーポレイション |
発現カセット
|
GB8407044D0
(en)
*
|
1984-03-19 |
1984-04-26 |
Fujisawa Pharmaceutical Co |
Producing human insulin
|
US5028531A
(en)
*
|
1984-03-19 |
1991-07-02 |
Fujisawa Pharmaceutical Company, Ltd. |
IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
|
US4656132A
(en)
|
1984-03-28 |
1987-04-07 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US4894334A
(en)
*
|
1984-03-28 |
1990-01-16 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US5268278A
(en)
*
|
1984-03-30 |
1993-12-07 |
Istituto Farmacologico Serono S.P.A. |
Genetic expression of somatostatin as hybrid polypeptide
|
US4789702A
(en)
*
|
1984-05-18 |
1988-12-06 |
Cetus Corporation |
Feline leukemia virus vaccine
|
US5683688A
(en)
*
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
DE3585176D1
(de)
*
|
1984-06-22 |
1992-02-27 |
Hitachi Ltd |
Verfahren zum kontrollieren der zuechtung von rekombinanten.
|
JPS619282A
(ja)
*
|
1984-06-22 |
1986-01-16 |
Hitachi Ltd |
遺伝子組換え菌の培養方法
|
EP0178764A1
(de)
*
|
1984-08-28 |
1986-04-23 |
Genex Corporation |
Verfahren zur Stabilisierung eines Wirtsmikroorganismus-Expressionsvektor-Systems für die Herstellung von Proteinen in grossem Umfang
|
US4738921A
(en)
*
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
NZ213759A
(en)
*
|
1984-10-19 |
1989-01-27 |
Genentech Inc |
Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
|
US5075224A
(en)
*
|
1984-10-19 |
1991-12-24 |
Genentech, Inc. |
Prepro-LHRH C-terminal peptide DNA
|
FI90990C
(fi)
*
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
WO1986004356A1
(en)
|
1985-01-28 |
1986-07-31 |
International Genetic Engineering, Inc. |
AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES
|
IT1234977B
(it)
*
|
1985-03-22 |
1992-06-09 |
Serono Ist Farm |
Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
|
DK171161B1
(da)
*
|
1985-03-28 |
1996-07-08 |
Hoffmann La Roche |
Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve
|
US4965188A
(en)
*
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
GB8509289D0
(en)
*
|
1985-04-11 |
1985-05-15 |
Fujisawa Pharmaceutical Co |
Production of somatostatin
|
DE3526995A1
(de)
*
|
1985-07-27 |
1987-02-05 |
Hoechst Ag |
Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
|
ES2000859A6
(es)
*
|
1985-08-12 |
1988-03-16 |
Syntex Inc |
Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
|
EP0213472A1
(de)
*
|
1985-08-12 |
1987-03-11 |
Syntex (U.S.A.) Inc. |
Verfahren zur Herstellung von Fusionsproteinen
|
JPH0775536B2
(ja)
*
|
1986-03-26 |
1995-08-16 |
猛 小林 |
遺伝子組み換え菌を用いた酵素生産装置
|
DE3642096A1
(de)
*
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
US6994988B1
(en)
|
1987-02-12 |
2006-02-07 |
Genetech, Inc. |
Methods and deoxyribonucleic acid for the preparation of tissue factor protein
|
JPH01247098A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
EP0335400B1
(de)
*
|
1988-03-30 |
1994-06-08 |
Hitachi, Ltd. |
Verfahren zur Herstellung von Epidermal-Wachstumsfaktor durch genetische Transformation
|
JPH01247099A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
JPH0227993A
(ja)
*
|
1988-07-15 |
1990-01-30 |
Nippon Shinyaku Co Ltd |
hEGFの製法
|
IL92937A0
(en)
|
1989-01-31 |
1990-09-17 |
Us Health |
Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
ES2109336T3
(es)
|
1990-11-26 |
1998-01-16 |
Genetics Inst |
Expresion de pace en celulas huesped y metodos de utilizacion de la misma.
|
PT786257E
(pt)
|
1992-06-03 |
2003-12-31 |
Genentech Inc |
Variantes de glicosilacao do activador de plasminogenio tissular com propriedades terapeuticas meloradas
|
GB9325182D0
(en)
*
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US6001604A
(en)
*
|
1993-12-29 |
1999-12-14 |
Bio-Technology General Corp. |
Refolding of proinsulins without addition of reducing agents
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
US6455304B1
(en)
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
US6113905A
(en)
*
|
1995-01-06 |
2000-09-05 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6015660A
(en)
*
|
1995-01-06 |
2000-01-18 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6077510A
(en)
*
|
1995-01-06 |
2000-06-20 |
Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US5795966A
(en)
|
1995-02-22 |
1998-08-18 |
Immunex Corp |
Antagonists of interleukin-15
|
DK1666591T3
(da)
|
1995-06-29 |
2011-05-23 |
Immunex Corp |
Cytokin der inducerer apoptose
|
US7005505B1
(en)
|
1995-08-25 |
2006-02-28 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor
|
US6020473A
(en)
*
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
US6998116B1
(en)
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
US6030945A
(en)
*
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
US6469144B1
(en)
|
1996-04-01 |
2002-10-22 |
Genentech, Inc. |
Apo-2LI and Apo-3 polypeptides
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US6462176B1
(en)
|
1996-09-23 |
2002-10-08 |
Genentech, Inc. |
Apo-3 polypeptide
|
US5990281A
(en)
*
|
1996-09-30 |
1999-11-23 |
Genentech, Inc. |
Vertebrate smoothened proteins
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
DE69738841D1
(de)
|
1996-12-23 |
2008-08-28 |
Immunex Corp |
Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
|
CA2572786A1
(en)
*
|
1997-04-04 |
1998-10-15 |
University Of Southern California |
Method for electrochemical fabrication including etching to remove flash
|
US6448035B1
(en)
|
1997-04-24 |
2002-09-10 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
|
US6384203B1
(en)
|
1999-05-12 |
2002-05-07 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
US6342369B1
(en)
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
CA2293724C
(en)
|
1997-06-05 |
2010-02-02 |
Xiaodong Wang |
Apaf-1, the ced-4 human homolog, an activator of caspase-3
|
EP2083079A1
(de)
|
1997-06-18 |
2009-07-29 |
Genentech, Inc. |
Apo-2DcR
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US6030619A
(en)
|
1997-08-27 |
2000-02-29 |
Chiron Corporation |
Molecular mimetics of meningococcal B epitopes
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
WO1999014330A1
(en)
|
1997-09-18 |
1999-03-25 |
Genentech, Inc. |
DcR3 POLYPEPTIDE, A TNFR HOMOLOG
|
IL135051A0
(en)
|
1997-10-10 |
2001-05-20 |
Genentech Inc |
Apo-3 ligand polypeptide
|
EP2033970A3
(de)
|
1997-10-29 |
2009-06-17 |
Genentech, Inc. |
WNT-1-induzierbare Gene
|
US6387657B1
(en)
|
1997-10-29 |
2002-05-14 |
Genentech, Inc. |
WISP polypeptides and nucleic acids encoding same
|
DE69828193T2
(de)
|
1997-10-31 |
2005-12-01 |
The Board Of Regents Of The University Of Oklahoma, Norman |
Hyaluronan synthase gen und seine verwendung
|
CN101113436B
(zh)
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
DE69841807D1
(de)
|
1997-11-06 |
2010-09-16 |
Novartis Vaccines & Diagnostic |
Neisseriale antigene
|
EP2014677A1
(de)
|
1997-11-21 |
2009-01-14 |
Genentech, Inc. |
Mit A33 vewandte Antigene und deren pharmazeutische Verwendung
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
DK1047784T4
(en)
|
1998-01-14 |
2015-06-15 |
Novartis Vaccines & Diagnostic |
NEISSERA meningitidis ANTIGENS
|
DK1045906T3
(da)
|
1998-01-15 |
2009-02-16 |
Genentech Inc |
APO-2-ligand
|
US6727079B1
(en)
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
ES2389387T3
(es)
|
1998-03-17 |
2012-10-25 |
Genentech, Inc. |
Polipéptidos homólogos de VEGF y de BMP1
|
US6987023B2
(en)
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
US20060188966A1
(en)
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US7223571B2
(en)
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP2261351A3
(de)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Antigene und Zusammensetzungen gegen Neisseria meningitidis
|
EP1865061A3
(de)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17-homologe Polypeptide und ihre therapeutische Verwendung
|
EP2333069A3
(de)
|
1998-05-15 |
2011-09-14 |
Genentech, Inc. |
Therapeutische verwendungen von il-17 homologe polypeptide
|
EP3112468A1
(de)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17-homologe polypeptide und therapeutische verwendung davon
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
EP1105485B1
(de)
|
1998-08-21 |
2006-07-05 |
Immunex Corporation |
Menschlisches il-1 epsilon dna und polypeptide
|
IL141734A0
(en)
|
1998-09-03 |
2002-03-10 |
Bristol Myers Squibb Co |
A process for preparing an amino lactam compound
|
DE69938190T2
(de)
|
1998-10-15 |
2009-03-05 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
|
US7094581B2
(en)
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
ATE519840T1
(de)
|
1998-12-16 |
2011-08-15 |
Novartis Vaccines & Diagnostic |
Menschliche cyclin-abhängige kinase (hpnqalre)
|
EP2075335A3
(de)
|
1998-12-22 |
2009-09-30 |
Genentech, Inc. |
Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
|
JP5456222B2
(ja)
|
1998-12-23 |
2014-03-26 |
ジェネンテック, インコーポレイテッド |
Il−1関連ポリペプチド
|
ES2477194T3
(es)
|
1999-04-30 |
2014-07-16 |
Novartis Vaccines And Diagnostics S.R.L. |
Ant�genos neisseriales conservados
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
AU5152700A
(en)
|
1999-06-15 |
2001-01-02 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7101989B1
(en)
|
1999-07-09 |
2006-09-05 |
University Of North Carolina At Chapel Hill |
DsrA protein and polynucleotides encoding the same
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
EP1305412A2
(de)
|
1999-10-14 |
2003-05-02 |
Clontech Laboratories Inc. |
Chromo/fluoroproteine aus anthozoa und verwendung der gleichen
|
CA2389317A1
(en)
|
1999-10-20 |
2001-04-26 |
Frederic J. De Sauvage |
Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
|
CN1796404A
(zh)
|
1999-10-29 |
2006-07-05 |
启龙有限公司 |
奈瑟球菌的抗原性肽
|
US7078382B1
(en)
|
1999-11-02 |
2006-07-18 |
Genentech, Inc. |
Modulation of eNOS activity and therapeutic uses thereof
|
CA2389990C
(en)
|
1999-11-10 |
2007-05-29 |
The University Of Washington |
Compositions and methods for modulation of plant cell division
|
CA2490853A1
(en)
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6824773B2
(en)
|
1999-12-20 |
2004-11-30 |
Immunex Corporation |
TWEAK receptor
|
DK1897945T3
(da)
|
1999-12-23 |
2012-05-07 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
|
ATE288493T1
(de)
|
1999-12-30 |
2005-02-15 |
Genencor Int |
Trichoderma reesei xylanase
|
EP1248841B1
(de)
|
2000-01-10 |
2008-07-23 |
Novartis Vaccines and Diagnostics, Inc. |
Gene differentiell experimiert in brudtkrebs
|
ATE424457T1
(de)
|
2000-01-13 |
2009-03-15 |
Genentech Inc |
Menschliche stra6 polypeptide
|
MXPA02006962A
(es)
|
2000-01-17 |
2002-12-13 |
Chiron Spa |
Vacuna de vesicula de membrana exterior que comprende proteinas de membrana exterior de neisseria meningitidis serogrupo b.
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
US7119085B2
(en)
|
2000-03-23 |
2006-10-10 |
Elan Pharmaceuticals, Inc. |
Methods to treat alzheimer's disease
|
CA2709771A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
DK2042597T3
(da)
|
2000-06-23 |
2014-08-11 |
Genentech Inc |
Sammensætninger og fremgangsmåder til diagnose og behandling af sygdomme, der involverer angiogenese
|
CA2410680A1
(en)
|
2000-06-30 |
2002-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
DE60136281D1
(de)
|
2000-08-24 |
2008-12-04 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(de)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäure zu deren Kodierung
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
AU2002214127B2
(en)
|
2000-10-27 |
2007-06-07 |
J. Craig Venter Institute, Inc. |
Nucleic acids and proteins from streptococcus groups A and B
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
AU2002303261A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
KR100886095B1
(ko)
|
2001-04-16 |
2009-02-27 |
와이어쓰 홀딩스 코포레이션 |
폴리펩티드 항원을 암호화하는 신규한 스트렙토코쿠스 뉴모니애 개방형 판독 프레임 및 이를 포함하는 조성물
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
US20060270003A1
(en)
|
2003-07-08 |
2006-11-30 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
CA2633171C
(en)
|
2001-06-20 |
2012-11-20 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
US6867189B2
(en)
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
CA2452836C
(en)
|
2001-07-27 |
2012-11-27 |
Chiron Srl |
Meningococcus adhesins nada, app and orf 40
|
MY144532A
(en)
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
HU230373B1
(hu)
|
2001-08-29 |
2016-03-29 |
Genentech Inc |
Mitogén aktivitású Bv8-nukleinsavak és polipeptidek
|
NZ573831A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT193
|
EP2335724A1
(de)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisierung gegen Chlamydia trachomatis
|
CA2467383C
(en)
|
2001-12-19 |
2012-08-28 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
NZ533933A
(en)
|
2002-01-02 |
2008-06-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of glioma tumor
|
EP1575480A4
(de)
|
2002-02-22 |
2008-08-06 |
Genentech Inc |
Zusammensetzungen und verfahren zur behandlung von immunbedingten erkrankungen
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
CA2481507A1
(en)
|
2002-04-16 |
2003-10-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2485695A1
(en)
|
2002-05-24 |
2003-12-04 |
Fred W. Wagner |
Method for universal enzymatic production of bioactive peptides
|
AU2003243316A1
(en)
|
2002-05-24 |
2003-12-12 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
US7700571B2
(en)
|
2002-06-05 |
2010-04-20 |
Genentech, Inc. |
Compositions and methods for liver growth and liver protection
|
AU2003243400B2
(en)
|
2002-06-07 |
2009-10-29 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2489588A1
(en)
|
2002-07-08 |
2004-01-15 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
AU2003276874B2
(en)
|
2002-09-11 |
2009-09-03 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
EP2277532A1
(de)
|
2002-09-11 |
2011-01-26 |
Genentech, Inc. |
Neuartige Zusammensetzung und Verfahren zur Behandlung von Immunerkrankungen
|
CA2498274A1
(en)
|
2002-09-16 |
2004-03-25 |
Genentech, Inc. |
Compositions and methods for the diagnosis of immune related diseases using pro7
|
EP1585482A4
(de)
|
2002-09-25 |
2009-09-09 |
Genentech Inc |
Neue zusammensetzungen und verfahren zur behandlung von psoriasis
|
AU2003278478A1
(en)
|
2002-10-04 |
2004-04-23 |
Firmenich Sa |
Sesquiterpene synthases and methods of use
|
WO2004039956A2
(en)
|
2002-10-29 |
2004-05-13 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP2006516094A
(ja)
|
2002-11-08 |
2006-06-22 |
ジェネンテック・インコーポレーテッド |
ナチュラルキラー細胞関連疾患の治療のための組成物と方法
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
EP2308968A1
(de)
|
2002-11-26 |
2011-04-13 |
Genentech, Inc. |
Zusammensetzung und Verfahren zur Behandlung von Immunerkrankungen
|
KR101118340B1
(ko)
|
2003-03-12 |
2012-04-12 |
제넨테크, 인크. |
조혈을 촉진하기 위한 bv8 및(또는) eg-vegf의용도
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7348420B2
(en)
|
2003-04-25 |
2008-03-25 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
|
AU2004252528B8
(en)
|
2003-06-23 |
2010-08-05 |
North Carolina State University |
Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
|
US7442785B2
(en)
|
2003-07-24 |
2008-10-28 |
The University Of Kentucky Research Foundation |
Sesquiterpene synthase gene and protein
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP1842920B2
(de)
|
2003-09-23 |
2017-06-21 |
University Of North Carolina At Chapel Hill |
Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
|
JP4777251B2
(ja)
|
2003-10-14 |
2011-09-21 |
バクスター・インターナショナル・インコーポレイテッド |
ビタミンkエポキシド還元酵素複合体サブユニット1vkorc1、クマリンおよびその誘導体の治療標的
|
PT2161283E
(pt)
|
2003-11-17 |
2014-08-29 |
Genentech Inc |
Composições que compreendem anticorpos contra cd79b conjugados a um agente de inibição do crescimento ou agente citotóxico e métodos para o tratamento de tumor de origem hematopoiética
|
SI1704234T1
(sl)
|
2003-11-21 |
2012-08-31 |
Nps Pharma Inc |
Proizvodnja glukagonu podobnih peptidov 2 in analogov
|
BRPI0507169A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
US7459289B2
(en)
|
2004-03-08 |
2008-12-02 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
|
WO2005093064A1
(ja)
|
2004-03-29 |
2005-10-06 |
Galpharma Co., Ltd. |
新規ガレクチン9改変体タンパク質及びその用途
|
US7250298B2
(en)
|
2004-04-07 |
2007-07-31 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
JP2008503217A
(ja)
|
2004-06-18 |
2008-02-07 |
アンブレツクス・インコーポレイテツド |
新規抗原結合ポリペプチド及びそれらの使用
|
AU2005333603A1
(en)
|
2004-10-21 |
2007-01-04 |
Wyeth |
Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens
|
AU2005318999B2
(en)
|
2004-12-22 |
2012-07-19 |
Genentech, Inc. |
Methods for producing soluble multi-membrane-spanning proteins
|
JP5425398B2
(ja)
|
2004-12-22 |
2014-02-26 |
アンブレツクス・インコーポレイテツド |
非天然アミノ酸及びポリペプチドを含む組成物、非天然アミノ酸及びポリペプチドに関連する方法並び非天然アミノ酸及びポリペプチドその使用
|
EP1836314B1
(de)
|
2004-12-22 |
2012-01-25 |
Ambrx, Inc. |
Modifiziertes menschliches wachstumshormon
|
CA2601574C
(en)
|
2005-03-15 |
2014-12-02 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
EA201201550A1
(ru)
|
2005-03-21 |
2013-08-30 |
Вайробей, Инк. |
Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз
|
JP2008537885A
(ja)
|
2005-04-15 |
2008-10-02 |
ノース・キャロライナ・ステイト・ユニヴァーシティ |
細菌の付着およびストレス耐性を修飾する方法および組成物
|
MX2007013431A
(es)
|
2005-05-04 |
2008-01-18 |
Zealand Pharma As |
Analogos del peptido 2 semejante al glucagon.
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
NZ563341A
(en)
|
2005-06-06 |
2009-10-30 |
Genentech Inc |
Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
|
EP1924136A4
(de)
|
2005-07-29 |
2009-05-13 |
Targeted Growth Inc |
Dominant-negative krp-proteinmutante als schutz gegen die hemmung von aktivem cyclin-cdk-komplex durch wildtyp-krp
|
AU2006280321A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
US7666817B2
(en)
|
2005-08-31 |
2010-02-23 |
The Regents Of The University Of California |
Cellular libraries of peptide sequences (CLiPS) and methods of using the same
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
DE102005048898A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
EP1942739B1
(de)
|
2005-10-18 |
2010-12-08 |
National Jewish Health |
Konditionell immortalisierte adulte langzeit-stammzellen und verfahren zur herstellung und verwendung von solchen zellen
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
US20090018029A1
(en)
|
2005-11-16 |
2009-01-15 |
Ambrx, Inc. |
Methods and Compositions Comprising Non-Natural Amino Acids
|
ZA200804162B
(en)
|
2005-11-21 |
2009-12-30 |
Genentech Inc |
Novel gene disruptions, compositions and methods relating thereto
|
US8026354B2
(en)
|
2005-11-23 |
2011-09-27 |
Institut Pasteur |
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
EP1973942B1
(de)
|
2005-12-22 |
2011-02-09 |
Genentech, Inc. |
Rekombinante produktion heparinbindender proteine
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
US20090288176A1
(en)
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
CA2650730A1
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
EP2054431B1
(de)
|
2006-06-09 |
2011-08-31 |
Novartis AG |
Bakterielle adhäsine konformere
|
EP2520586A1
(de)
|
2006-06-30 |
2012-11-07 |
The Regents of the University of Michigan |
Verfahren zur Herstellung von Faktor-VIII-Proteinen durch Rekombinationsverfahren
|
JP5840345B2
(ja)
|
2006-09-08 |
2016-01-06 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾ヒト血漿ポリペプチドまたは修飾ヒトFc足場タンパク質ならびにこれらの利用
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
EP3284825B1
(de)
|
2006-11-02 |
2021-04-07 |
Biomolecular Holdings LLC |
Verfahren zur herstellung von hybriden polypeptiden mit beweglichen teilen
|
WO2008103962A2
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
KR101476472B1
(ko)
|
2007-03-30 |
2015-01-05 |
암브룩스, 인코포레이티드 |
변형된 fgf-21 폴리펩티드 및 그 용도
|
WO2008131208A1
(en)
|
2007-04-20 |
2008-10-30 |
Enzon Pharmaceuticals, Inc. |
Stable recombinant adenosine deaminase
|
EP2139499A4
(de)
|
2007-04-26 |
2010-05-05 |
Inspiration Biopharmaceuticals |
Rekombinante vitamin-k-abhängige proteine mit hohem sialsäuregehalt und verfahren zu ihrer herstellung
|
CN101802013B
(zh)
|
2007-07-16 |
2014-07-02 |
健泰科生物技术公司 |
人源化抗cd79b抗体和免疫偶联物及使用方法
|
NZ583367A
(en)
|
2007-07-16 |
2012-10-26 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
CA2697992C
(en)
|
2007-10-04 |
2017-08-22 |
Zymogenetics, Inc. |
B7 family member zb7h6 and related compositions and methods
|
US20090233991A1
(en)
|
2007-11-01 |
2009-09-17 |
Hee Cheol Cho |
Generation of biological pacemaker activity
|
WO2009059305A2
(en)
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
DK2217265T3
(en)
|
2007-11-20 |
2017-07-03 |
Ambrx Inc |
Modified insulin polypeptides and their use
|
EP2586797A3
(de)
|
2007-11-27 |
2013-07-24 |
Medtronic, Inc. |
Humanisierte beta-Antikörper für Amyloid-beta
|
WO2009073511A2
(en)
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
MX2010008437A
(es)
|
2008-01-31 |
2010-11-25 |
Genentech Inc |
Anticuerpos anti-cd79b e inmunoconjugados y metodos de uso.
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
EP2245048B1
(de)
|
2008-02-21 |
2014-12-31 |
Novartis AG |
Meningokokken-fhbp-polypeptide
|
EP2279412B1
(de)
|
2008-04-09 |
2017-07-26 |
Genentech, Inc. |
Neue zusammensetzungen und verfahren zur behandlung von immunkrankheiten
|
SG10201803982TA
(en)
|
2008-05-16 |
2018-07-30 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
EP3225248B1
(de)
|
2008-07-23 |
2023-06-07 |
Ambrx, Inc. |
Modifizierte bovine g-csf-polypeptide und ihre verwendung
|
DK2318435T3
(en)
|
2008-08-28 |
2016-02-29 |
Taiga Biotechnologies Inc |
Modulators of MYC, methods of using the same, and methods for identifying agents that modulate MYC
|
AU2009296397B2
(en)
|
2008-09-26 |
2012-11-08 |
Ambrx Inc. |
Modified animal erythropoietin polypeptides and their uses
|
KR101732054B1
(ko)
|
2008-09-26 |
2017-05-02 |
암브룩스, 인코포레이티드 |
비천연 아미노산 복제 의존성 미생물 및 백신
|
US9702877B2
(en)
|
2008-10-31 |
2017-07-11 |
Quest Diagnostics Investments Incorporated |
BCR-ABL variants
|
AU2009319772A1
(en)
|
2008-11-26 |
2010-06-03 |
Centocor Research & Development, Inc. |
Compositions and methods for regulating collagen and smooth muscle actin expression by SERPINE2
|
PT2393828T
(pt)
|
2009-02-03 |
2017-01-18 |
Amunix Operating Inc |
Polipéptidos recombinantes estendidos e composições que compreendem os mesmos
|
WO2010120561A1
(en)
|
2009-04-01 |
2010-10-21 |
Genentech, Inc. |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
EP2251025A1
(de)
|
2009-05-12 |
2010-11-17 |
Universitat Autònoma De Barcelona |
Verwendung von Einschlusskörpern als therapeutische Wirkstoffe
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
NZ596787A
(en)
|
2009-06-08 |
2014-03-28 |
Amunix Operating Inc |
Growth hormone polypeptides and methods of making and using same
|
BR112012000032A2
(pt)
|
2009-07-03 |
2016-03-15 |
Bionor Immuno As |
meios terapêuticos e diagnósticos inovadores
|
JP5813641B2
(ja)
|
2009-08-24 |
2015-11-17 |
アムニクス オペレーティング インコーポレイテッド |
凝固第ix因子組成物ならびにそれを製造および使用する方法
|
CN102596240B
(zh)
|
2009-08-27 |
2015-02-04 |
诺华股份有限公司 |
包括脑膜炎球菌fHBP序列的杂交多肽
|
WO2011041308A1
(en)
|
2009-09-30 |
2011-04-07 |
Quest Diagnostics Investments Incorporated |
Bcr-abl truncation mutations
|
US20120219952A1
(en)
|
2009-10-06 |
2012-08-30 |
Patrice Nordmann |
Carbapenemase and antibacterial treatment
|
EP2488643A4
(de)
|
2009-10-15 |
2013-07-03 |
Hoffmann La Roche |
Chimäre fibroblastwachstumsfaktoren mit veränderter rezeptorspezifizität
|
KR20120105446A
(ko)
|
2009-10-22 |
2012-09-25 |
제넨테크, 인크. |
대식세포-자극 단백질의 헵신 활성화를 조정하기 위한 방법 및 조성물
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
MX2012004850A
(es)
|
2009-10-27 |
2012-05-22 |
Novartis Ag |
Polipeptidos fhbp meningococicos modificados.
|
RU2012124093A
(ru)
|
2009-11-12 |
2013-12-20 |
Дженентек, Инк. |
Способ увеличения плотности дендритных шипиков
|
AU2010324686B2
(en)
|
2009-11-30 |
2016-05-19 |
Genentech, Inc. |
Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID2 )
|
NZ600363A
(en)
|
2009-12-21 |
2014-07-25 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
EP2805964A1
(de)
|
2009-12-21 |
2014-11-26 |
Ambrx, Inc. |
Modifizierte Rinder-Somatotropinpolypeptide und deren Verwendungen
|
FR2954349A1
(fr)
|
2009-12-22 |
2011-06-24 |
Agronomique Inst Nat Rech |
Sulfatase modifiant selectivement les glycosaminoglycanes
|
US8877897B2
(en)
|
2010-02-23 |
2014-11-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
BR112012028010A2
(pt)
|
2010-05-03 |
2017-09-26 |
Genentech Inc |
anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero
|
WO2011146715A1
(en)
|
2010-05-19 |
2011-11-24 |
North Carolina State University |
Compositions and methods for the delivery of therapeutic peptides
|
WO2011149461A1
(en)
|
2010-05-27 |
2011-12-01 |
Medtronic, Inc. |
Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
|
CA2800206C
(en)
|
2010-06-25 |
2018-06-05 |
(Inserm) Institut National De La Sante Et De La Recherche Medicale |
Methods and pharmaceutical compositions for the treatment of respiratory tract infections
|
BR112013003646B1
(pt)
|
2010-07-29 |
2021-09-08 |
Eleven Biotherapeutics, Inc. |
Proteína isolada que compreende um domínio de citocina da família de interleucina-1 (il-1) quimérica, seu método de preparação, composição farmacêutica e usos, bem como, ácido nucleico, vetor, e célula hospedeira
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
DK2605789T3
(da)
|
2010-08-17 |
2019-09-16 |
Ambrx Inc |
Modificerede relaxinpolypeptider og anvendelser deraf
|
EP2420253A1
(de)
|
2010-08-20 |
2012-02-22 |
Leadartis, S.L. |
Manipulation multifunktioneller und multivalenter Moleküle mit Kollagen-XV-Trimerisationsdomäne
|
US8729233B2
(en)
|
2010-08-30 |
2014-05-20 |
Board Of Trustees Of Michigan State University |
Microbial nanowires and products related thereto
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
JP2014506115A
(ja)
|
2010-09-15 |
2014-03-13 |
アリグナ テクノロジーズ,インク. |
リグニン由来の化合物からの芳香族化学物質のバイオプロダクション
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP2441776A1
(de)
|
2010-10-15 |
2012-04-18 |
Leadartis, S.L. |
Erzeugung multifunktionaler und multivalenter Polypeptidkomplexe mit Kollagen-XVIII-Trimerisationsdomäne
|
EP2646465B1
(de)
|
2010-10-15 |
2018-09-12 |
Leadartis, S.L. |
Erzeugung multifunktionaler und multivalenter polypeptidkomplexe mit kollagen-xviii-trimerisationsdomäne
|
US9631002B2
(en)
|
2010-12-21 |
2017-04-25 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin K-dependent proteins
|
US8603740B2
(en)
|
2010-12-29 |
2013-12-10 |
Quest Diagnostics Investments Incorporated |
BCR-ABL1 splice variants and uses thereof
|
WO2012095684A1
(en)
|
2011-01-10 |
2012-07-19 |
Inserm ( Institut National De La Sante Et De La Recherche Medicale) |
Methods for the screening of substances useful for the prevention and treatment of neisseria infections
|
WO2012103240A2
(en)
|
2011-01-25 |
2012-08-02 |
Eleven Biotherapeutics, Inc. |
Receptor binding agents
|
CN103533951B
(zh)
|
2011-04-08 |
2017-04-19 |
安姆根有限公司 |
使用生长分化因子15(gdf‑15)治疗或改善代谢障碍的方法
|
WO2013011072A1
(en)
|
2011-07-20 |
2013-01-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
CN104066439A
(zh)
|
2011-07-29 |
2014-09-24 |
十一生物治疗股份有限公司 |
纯化的蛋白质
|
WO2013033456A2
(en)
|
2011-09-02 |
2013-03-07 |
Board Of Trustees Of Michigan State University |
Microbial nanowires and methods of making and using
|
CA2862745A1
(en)
|
2012-01-26 |
2013-08-01 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
PL3564260T3
(pl)
|
2012-02-15 |
2023-03-06 |
Bioverativ Therapeutics Inc. |
Kompozycje czynnika viii oraz sposoby ich wytwarzania i stosowania
|
HUE043537T2
(hu)
|
2012-02-15 |
2019-08-28 |
Bioverativ Therapeutics Inc |
Rekombináns VIII faktor fehérjék
|
US10172953B2
(en)
|
2012-02-27 |
2019-01-08 |
Amunix Operating Inc. |
XTEN conjugate compositions and methods of making same
|
AU2013240280A1
(en)
|
2012-03-27 |
2014-10-16 |
Genentech, Inc. |
Improved harvest operations for recombinant proteins
|
EP2841087B1
(de)
|
2012-04-27 |
2017-08-23 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Antagonisten gegen den vaskulären endothelialen wachstumsfaktor und verfahren zu deren verwendung
|
US9453064B2
(en)
|
2012-05-03 |
2016-09-27 |
Zealand Pharma A/S |
Glucagon-like-peptide-2 (GLP-2) analogues
|
CA2874936A1
(en)
|
2012-06-06 |
2013-12-12 |
Bionor Immuno As |
Vaccine
|
EP3868387A1
(de)
|
2012-07-20 |
2021-08-25 |
Taiga Biotechnologies, Inc. |
Verbesserte wiederherstellung und autorenkonstitution des hämatopoietischen abteils
|
WO2014026136A2
(en)
|
2012-08-10 |
2014-02-13 |
Cytomx Therapeutics, Inc. |
Protease-resistant systems for polypeptide display and methods of making and using thereof
|
CA2892038C
(en)
|
2012-11-20 |
2021-12-28 |
Darrel W. Stafford |
Methods and compositions for modified factor ix proteins
|
US20160186221A1
(en)
|
2012-12-07 |
2016-06-30 |
Danisco Us Inc. |
Compositions and methods of use
|
EP2929021A1
(de)
|
2012-12-07 |
2015-10-14 |
Danisco US Inc. |
Zusammensetzungen und verfahren zur verwendung
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
ES2884813T3
(es)
|
2013-03-13 |
2021-12-13 |
Buzzard Pharmaceuticals AB |
Formulaciones de citoquina quimérica para administración ocular
|
UA118843C2
(uk)
|
2013-03-15 |
2019-03-25 |
Дженентек, Інк. |
ХИМЕРНИЙ БІЛОК IL-22 Fc ТА ЙОГО ЗАСТОСУВАННЯ
|
ES2759061T3
(es)
|
2013-03-15 |
2020-05-07 |
Biomolecular Holdings Llc |
Inmunoglobulina híbrida que contiene unión no peptidílica
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
MX2016005614A
(es)
|
2013-11-01 |
2016-12-09 |
Spherium Biomed S L |
Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
AU2015229186B2
(en)
|
2014-03-14 |
2021-01-28 |
Biomolecular Holdings Llc |
Hybrid immunoglobulin containing non-peptidyl linkage
|
CA2951616A1
(en)
|
2014-07-11 |
2016-01-14 |
Bionor Immuno As |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
EP3201333A1
(de)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Zusammensetzungen mit beta-mannanase und verfahren zur verwendung
|
WO2016054205A1
(en)
|
2014-09-30 |
2016-04-07 |
Danisco Us Inc |
Compositions comprising beta mannanase and methods of use
|
EP3201331A1
(de)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Zusammensetzungen mit beta-mannanase und verfahren zur verwendung
|
WO2016054194A1
(en)
|
2014-09-30 |
2016-04-07 |
1/1Danisco Us Inc |
Compositions comprising beta-mannanase and methods of use
|
EP3201332A1
(de)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Zusammensetzungen mit beta-mannanase und verfahren zur verwendung
|
UY36370A
(es)
|
2014-10-24 |
2016-04-29 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Polipéptidos fgf-21 modificados y sus usos
|
WO2016100825A1
(en)
|
2014-12-18 |
2016-06-23 |
Danisco Us Inc |
Engineered multifunctional enzymes and methods of use
|
US20170362621A1
(en)
|
2014-12-18 |
2017-12-21 |
Danisco Us Inc. |
Engineered multifunctional enzymes and methods of use
|
CA2975734A1
(en)
|
2015-02-06 |
2016-08-11 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting factor viii gene expression cassettes and their use
|
CN108040485A
(zh)
|
2015-03-31 |
2018-05-15 |
诺夫免疫股份有限公司 |
用于优化异源多聚体蛋白质复合物的装配和生产的方法
|
JP2018515603A
(ja)
|
2015-05-04 |
2018-06-14 |
ビオノル・イムノ・アクシェセルスカプBionor Immuno AS |
Hivワクチン用の投薬レジメン
|
BR112018002150A2
(pt)
|
2015-08-03 |
2018-09-18 |
Bioverativ Therapeutics Inc |
proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
|
KR20180038560A
(ko)
|
2015-08-28 |
2018-04-16 |
아뮤닉스 오퍼레이팅 인코포레이티드 |
키메라 폴리펩티드 조립체와 이의 제조 및 사용 방법
|
MX2018011834A
(es)
|
2016-03-29 |
2019-03-06 |
Geltor Inc |
Expresión de proteínas en bacterias gram negativas en la que la relación del volumen periplasmático con respecto al volumen citoplasmático está entre 0.5:1 y 10:1.
|
CN109328069B
(zh)
|
2016-04-15 |
2023-09-01 |
亿一生物医药开发(上海)有限公司 |
Il-22在治疗坏死性小肠结肠炎中的用途
|
US10590426B2
(en)
|
2016-08-22 |
2020-03-17 |
Board Of Trustees Of Michigan State University |
Genetic control of cell size
|
CN113786476A
(zh)
|
2016-12-02 |
2021-12-14 |
泰加生物工艺学公司 |
纳米颗粒调配物
|
AU2017370682A1
(en)
|
2016-12-06 |
2019-06-20 |
Kaleido Biosciences, Inc. |
Glycan polymers and related methods thereof
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
ES2963839T3
(es)
|
2017-02-08 |
2024-04-02 |
Bristol Myers Squibb Co |
Polipéptidos de relaxina modificados que comprenden un potenciador farmacocinético y usos de los mismos
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
AU2017425657A1
(en)
|
2017-08-03 |
2020-02-13 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
KR20200115546A
(ko)
|
2018-01-26 |
2020-10-07 |
제넨테크, 인크. |
IL-22 Fc 융합 단백질 및 사용 방법
|
BR112020015016A2
(pt)
|
2018-01-26 |
2020-12-29 |
Genentech, Inc. |
Composições farmacêuticas, métodos de tratamento da doença inflamatória intestinal, de inibição da infecção microbiana no intestino e de aceleração ou melhora da cicatrização de feridas
|
AU2019226085A1
(en)
|
2018-02-21 |
2020-09-17 |
Genentech, Inc. |
Dosing for treatment with IL-22 Fc fusion proteins
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3773656A1
(de)
|
2018-04-09 |
2021-02-17 |
Amgen Inc. |
Wachstumsdifferenzierungsfaktor-15-fusionsproteine
|
JP2021525537A
(ja)
|
2018-06-06 |
2021-09-27 |
レアダルティス、ソシエダッド リミターダLeadartis, S.L. |
三量体ポリペプチド複合体およびその使用
|
JP7441826B2
(ja)
|
2018-09-11 |
2024-03-01 |
アンブルックス,インコーポレイテッド |
インターロイキン-2ポリペプチド抱合物およびその使用
|
EP3946611A2
(de)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Antivirale und antitumorale verbindungen
|
SG11202111349QA
(en)
|
2019-04-12 |
2021-11-29 |
Geltor Inc |
Recombinant elastin and production thereof
|
CA3174114A1
(en)
|
2020-03-11 |
2021-09-16 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
WO2021207662A1
(en)
|
2020-04-10 |
2021-10-14 |
Genentech, Inc. |
Use of il-22fc for the treatment or prevention of pneumonia, acute respiratory distress syndrome, or cytokine release syndrome
|
IL288680A
(en)
|
2021-12-05 |
2023-07-01 |
Yeda Res & Dev |
Genetically modified phages and their use
|